Wickham Labs to exhibit at Making Pharmaceuticals 2017
13 March 2017 | By Wickham Labs
Wickham Laboratories Ltd will exhibit on Stand 309 at the Making Pharmaceuticals Conference on the 25th – 26th April 2017...
List view / Grid view
News
European experts meet with Afican regulators to discuss collaboration
10 March 2017 | By Steve Bremer, Managing Editor
Representatives from the European Medicines Agency (EMA) met with medicines regulators from Africa last week to discuss how to improve the availability of high quality, safe and effective medicines to patients in countries beyond Europe. One of the tools discussed was the scientific assessment of medicines or vaccines for use…
Global trade bodies issue guidance on biosimilar switching
9 March 2017 | By European Pharmaceutical Review
EFPIA, EBE and IFPMA issue joint guidance for prescribers on switching between original reference biologics and biosimilars...
Head and neck cancer market fertile for investment
8 March 2017 | By GBI Research
A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, which could potentially transform the clinical and commercial landscape, according to business intelligence firm GBI Research.
Ocean FX Spectrometer Provides High Acquisition Speed
Newest spectrometer from Ocean Optics offers Ethernet operation, speed, sensitivity and spectral buffering...
Price drops make more cancer drugs routinely available
7 March 2017 | By Steve Bremer, Managing Editor
The National Institute for Health and Care Excellence (NICE) is half way through a review of drugs approved and still available only through the old Cancer Drugs Fund (CDF). In all cases so far where NICE has been able to make recommendations for routine NHS use, companies have reviewed and…
Watson-Marlow launches new bioprocessing pump technology at INTERPHEX 2017
7 March 2017 | By Watson-Marlow
Watson-Marlow Fluid Technology Group (WMFTG) the world leader in peristaltic pumps and associated fluid path technologies, will be unveiling a host of products at INTERPHEX 2017 including a new bioprocessing pump. Visitors to booth 2833 will witness a step change in tangential flow filtration (TFF), virus filtration (VF) and high-performance…
UK life sciences sector productivity double national average
7 March 2017 | By Steve Bremer, Managing Editor
The PwC report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British In Vitro Diagnostics Association (BIVDA), shows that the average productivity of UK life sciences employees, expressed as gross value…
AbbVie receives CHMP positive opinion for Hep C tablet combination
2 March 2017 | By Niamh Marriott, Digital Editor
The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for Abbvie’s shorter, eight-week treatment of Viekirax (ombitasvir/paritaprevir/ritonavir tablets) + Exviera (dasabuvir tablets) as an option for previously untreated adult patients with geotype 1b chronic hepatitis C virus (HCV)…
NICE does not recommend Merck’s lung cancer drug
2 March 2017 | By Niamh Marriott, Digital Editor
NICE has published draft guidance which does not recommend Keytruda, also known as pembrolizumab, for untreated PD-L1-positive metastatic lung cancer...
Richmond unveils new clinical research centre in central London
1 March 2017 | By Niamh Marriott, Digital Editor
European Pharmaceutical Review was invited to the grand opening Richmond Pharmacology's new clinical research facility in central London.
Janssen’s monoclonal antibody receives positive CHMP opinion to treat multiple myeloma
28 February 2017 | By Niamh Marriott, Digital Editor
If approved by the European Commission, daratumumab can be used for the treatment of adult patients with multiple myeloma...
Novartis receives positive CHMP opinion for lung cancer combination
27 February 2017 | By Niamh Marriott, Digital Editor
The EMA approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with non-small cell lung cancer...
AstraZeneca Phase III breast cancer trial met primary endpoint
23 February 2017 | By Niamh Marriott, Digital Editor
AstraZeneca announced positive results from its Phase III trial comparing Lynparza to chemotherapy, to treat HER2-negative metastatic breast cancer...
First biosimilar mAb in oncology granted EU approval
23 February 2017 | By Niamh Marriott, Digital Editor
The European Commission has approved Truxima (biosimilar rituximab) for all indications of reference rituximab in the European Union.
